• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fontan 结局网络:为美国 Fontan 循环个体建立寿命登记处的初步尝试。

The Fontan outcomes network: first steps towards building a lifespan registry for individuals with Fontan circulation in the United States.

机构信息

Heart Institute, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH, USA.

Division of Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.

出版信息

Cardiol Young. 2020 Aug;30(8):1070-1075. doi: 10.1017/S1047951120001869. Epub 2020 Jul 8.

DOI:10.1017/S1047951120001869
PMID:32635947
Abstract

The Fontan Outcomes Network was created to improve outcomes for children and adults with single ventricle CHD living with Fontan circulation. The network mission is to optimise longevity and quality of life by improving physical health, neurodevelopmental outcomes, resilience, and emotional health for these individuals and their families. This manuscript describes the systematic design of this new learning health network, including the initial steps in development of a national, lifespan registry, and pilot testing of data collection forms at 10 congenital heart centres.

摘要

Fontan 结局网络的创建是为了改善患有单心室 CHD 并接受 Fontan 循环治疗的儿童和成人的结局。该网络的使命是通过改善这些个体及其家庭的身体健康、神经发育结局、适应能力和心理健康来优化其寿命和生活质量。本手稿描述了这个新的学习健康网络的系统设计,包括在 10 个先天性心脏病中心开展国家范围的终生注册和数据收集表格试点测试的初步步骤。

相似文献

1
The Fontan outcomes network: first steps towards building a lifespan registry for individuals with Fontan circulation in the United States.Fontan 结局网络:为美国 Fontan 循环个体建立寿命登记处的初步尝试。
Cardiol Young. 2020 Aug;30(8):1070-1075. doi: 10.1017/S1047951120001869. Epub 2020 Jul 8.
2
The Australia and New Zealand Fontan Registry: description and initial results from the first population-based Fontan registry.澳大利亚和新西兰Fontan注册研究:首个基于人群的Fontan注册研究的描述与初步结果
Intern Med J. 2014 Feb;44(2):148-55. doi: 10.1111/imj.12318.
3
The Australian and New Zealand Fontan Registry Quality of Life Study: Protocol for a population-based assessment of quality of life among people with a Fontan circulation, their parents, and siblings.澳大利亚和新西兰 Fontan 注册处生活质量研究:基于人群的 Fontan 循环人群及其父母和兄弟姐妹生活质量评估方案。
BMJ Open. 2022 Sep 20;12(9):e065726. doi: 10.1136/bmjopen-2022-065726.
4
Two Ventricles Are Not Better Than One in the Fontan Circulation: Equivalent Late Outcomes.双心室并不优于 Fontan 循环中的单心室:等效的晚期结局。
Ann Thorac Surg. 2019 Mar;107(3):852-859. doi: 10.1016/j.athoracsur.2018.08.024. Epub 2018 Oct 6.
5
Health-Related Quality of Life in Children, Adolescents, and Adults With a Fontan Circulation: A Meta-Analysis.成人体内心肺转流患儿健康相关生活质量的 Meta 分析
J Am Heart Assoc. 2020 Mar 17;9(6):e014172. doi: 10.1161/JAHA.119.014172. Epub 2020 Mar 16.
6
The adult Fontan patient: update for 2011.成人Fontan手术患者:2011年最新进展
Methodist Debakey Cardiovasc J. 2011 Apr-Jun;7(2):3-8. doi: 10.14797/mdcj-7-2-3.
7
Can a Home-based Cardiac Physical Activity Program Improve the Physical Function Quality of Life in Children with Fontan Circulation?基于家庭的心脏体育活动计划能否改善Fontan循环患儿的身体功能和生活质量?
Congenit Heart Dis. 2016 Mar-Apr;11(2):175-82. doi: 10.1111/chd.12330. Epub 2016 Feb 16.
8
Use of ACE inhibitors in Fontan: Rational or irrational?在Fontan手术中使用血管紧张素转换酶抑制剂:合理还是不合理?
Int J Cardiol. 2016 May 1;210:95-9. doi: 10.1016/j.ijcard.2016.02.089. Epub 2016 Feb 18.
9
Longitudinal Outcomes of Patients With Single Ventricle After the Fontan Procedure.Fontan手术后单心室患者的纵向预后
J Am Coll Cardiol. 2017 Jun 6;69(22):2735-2744. doi: 10.1016/j.jacc.2017.03.582.
10
Reaching consensus for unified medical language in Fontan care.为 Fontan 治疗达成统一医学语言的共识。
ESC Heart Fail. 2021 Oct;8(5):3894-3905. doi: 10.1002/ehf2.13294. Epub 2021 Jun 30.

引用本文的文献

1
One Ventricle, 3000 Proteins: Unraveling the Molecular Landscape of the Fontan Circulation.单心室,3000种蛋白质:解析Fontan循环的分子图景。
J Am Heart Assoc. 2025 May 20;14(10):e042351. doi: 10.1161/JAHA.125.042351. Epub 2025 May 15.
2
Evaluating Hospital Resource Utilization for Hypoplastic Left Heart Syndrome Through Linkage of a Clinical Registry and an Administrative Database.通过临床登记系统与行政数据库的关联来评估左心发育不全综合征的医院资源利用情况。
Pediatr Cardiol. 2025 Mar 11. doi: 10.1007/s00246-025-03814-8.
3
Are Arrhythmias Adequately Incorporated into Studies on Long-Term Outcomes After the Fontan Operation?
心律失常是否充分纳入了Fontan手术后长期结局的研究中?
Pediatr Cardiol. 2025 Feb 21. doi: 10.1007/s00246-025-03789-6.
4
The Future of the Fontan Circulation: A Call for Innovation and Collaboration.Fontan循环的未来:呼吁创新与合作。
JACC Case Rep. 2025 Jan 2;30(1):103031. doi: 10.1016/j.jaccas.2024.103031. eCollection 2025 Jan 1.
5
Protein losing enteropathy after the Fontan operation.Fontan手术后的蛋白丢失性肠病。
Int J Cardiol Congenit Heart Dis. 2022 Jan 26;7:100338. doi: 10.1016/j.ijcchd.2022.100338. eCollection 2022 Mar.
6
Artificial Intelligence in Congenital Heart Disease: Current State and Prospects.先天性心脏病中的人工智能:现状与前景
JACC Adv. 2022 Dec 14;1(5):100153. doi: 10.1016/j.jacadv.2022.100153. eCollection 2022 Dec.
7
Surrogates of Muscle Mass on Cardiac MRI Correlate with Exercise Capacity in Patients with Fontan Circulation.心脏磁共振成像中肌肉量的替代指标与Fontan循环患者的运动能力相关。
J Clin Med. 2023 Apr 4;12(7):2689. doi: 10.3390/jcm12072689.
8
A Path FORWARD: Development of a Comprehensive Multidisciplinary Clinic to Create Health and Wellness for the Child and Adolescent with a Fontan Circulation.一个前进的道路:为患有法洛四联症的儿童和青少年创建健康和保健的综合多学科诊所的发展。
Pediatr Cardiol. 2022 Aug;43(6):1175-1192. doi: 10.1007/s00246-022-02930-z. Epub 2022 May 23.
9
Methods to Establish Race or Ethnicity of Twitter Users: Scoping Review.方法建立种族或族裔的 Twitter 用户:范围审查。
J Med Internet Res. 2022 Apr 29;24(4):e35788. doi: 10.2196/35788.
10
You can only change what you measure: an argument for more detailed characterization in the Fontan circulation.你只能改变你所测量的东西:关于在Fontan循环中进行更详细特征描述的观点。
Eur Heart J. 2022 Jul 1;43(25):2385-2387. doi: 10.1093/eurheartj/ehac010.